AAPL   381.91 (-0.46%)
FB   239.00 (-2.48%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
AAPL   381.91 (-0.46%)
FB   239.00 (-2.48%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
AAPL   381.91 (-0.46%)
FB   239.00 (-2.48%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
AAPL   381.91 (-0.46%)
FB   239.00 (-2.48%)
GOOGL   1,512.23 (-1.74%)
AMZN   3,104.00 (-3.00%)
NVDA   402.09 (-4.07%)
BABA   251.67 (-3.58%)
MU   49.46 (-2.45%)
GE   6.70 (+0.15%)
TSLA   1,497.06 (-3.08%)
AMD   53.59 (-4.10%)
T   29.76 (-1.23%)
DIS   116.22 (-2.61%)
NFLX   525.50 (-4.23%)
BAC   24.19 (+0.71%)
Log in

OTCMKTS:PHMMFPharma Mar Stock Price, Forecast & News

$10.98
+0.18 (+1.67 %)
(As of 07/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$10.98
Now: $10.98
$11.05
50-Day Range
$6.16
MA: $7.81
$11.16
52-Week Range
$1.68
Now: $10.98
$11.35
Volume1,300 shs
Average Volume7,375 shs
Market Capitalization$2.43 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.57
Pharma Mar, S.A., a biopharmaceutical company, engages in the discovery and development of marine-derived anticancer drugs in Spain and internationally. The company operates through two segments, Biopharmaceuticals and Consumer Chemicals. It develops and commercializes Yondelis, an antitumor agent for the treatment of advanced soft tissue sarcomas and for relapsed ovarian cancer. The company also develops clinical-stage programs, including Aplidin, Lurbinectedin, PM184, and PM14. In addition, it develops and provides diagnostics kit for genetic diagnostics and DNA analysis; and produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Pharma Mar, S.A. was founded in 1986 and is based in Madrid, Spain.
Read More
Pharma Mar logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars


Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PHMMF
Previous SymbolNASDAQ:PHMMF
CUSIPN/A
CIKN/A
Phone34-91-846-6000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$192.01 million
Book Value$0.09 per share

Profitability

Miscellaneous

Employees599
Market Cap$2.43 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive PHMMF News and Ratings via Email

Sign-up to receive the latest news and ratings for PHMMF and its competitors with MarketBeat's FREE daily newsletter.

Pharma Mar (OTCMKTS:PHMMF) Frequently Asked Questions

How has Pharma Mar's stock been impacted by COVID-19 (Coronavirus)?

Pharma Mar's stock was trading at $3.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, PHMMF stock has increased by 213.7% and is now trading at $10.98. View which stocks have been most impacted by Coronavirus.

Has Pharma Mar been receiving favorable news coverage?

Media coverage about PHMMF stock has been trending very negative recently, according to InfoTrie Sentiment. The research firm scores the sentiment of media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Pharma Mar earned a news impact score of -3.2 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about Pharma Mar.

Who are some of Pharma Mar's key competitors?

Who are Pharma Mar's key executives?

Pharma Mar's management team includes the following people:
  • Dr. José María Fernández Sousa-Faro Ph.D., Founder, Exec. Chairman, CEO & Pres
  • Mr. Pedro Fernández Puentes, Exec. Vice-Chairman
  • Mr. Juan Carlos-Torres Carretero, Founder (Age 70)
  • Ms. María Luisa de Francia Caballero, Chief Financial Officer
  • Mr. Pascal Besman, Chief Operating Officer

What is Pharma Mar's stock symbol?

Pharma Mar trades on the OTCMKTS under the ticker symbol "PHMMF."

How do I buy shares of Pharma Mar?

Shares of PHMMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Pharma Mar's stock price today?

One share of PHMMF stock can currently be purchased for approximately $10.98.

How big of a company is Pharma Mar?

Pharma Mar has a market capitalization of $2.43 billion and generates $192.01 million in revenue each year. Pharma Mar employs 599 workers across the globe.

What is Pharma Mar's official website?

The official website for Pharma Mar is www.pharmamar.com.

How can I contact Pharma Mar?

Pharma Mar's mailing address is Avda. De los Reyes 1 Pol. Ind. La Mina, Madrid U3, 28770. The company can be reached via phone at 34-91-846-6000 or via email at [email protected]

This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.